Probiotics in aging skin

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 811-820

  Cinque, Benedetta ^a   Palumbo, Paola ^a   La Torre, Cristina ^a   Melchiorre, Esterina ^a   Corridoni, Daniele ^a   Miconi, Gianfranca ^a   Marzio, Luisa Di ^a   Cifone, Maria Grazia ^a   Giuliani, Maurizio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892009227     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_78     Document Type: Chapter

References (75)

1. Fioramonti J, et al. Probiotics: What are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol. 2003;17 (5):711-724.
2. Reid G. How science will help shape future clinical applications of probiotics. Clin Infect Dis. 2008;46(Suppl. 2):S62-S66.
3. Silva M, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother. 1987;31:1231-1233.
4. Heczko PB, et al. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol. 2006;57(Suppl 9):S5-S12.
5. Gionchetti P, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol. 2006;12:3306-3313.
6. Farnworth ER. The evidence to support health claims for probiotics. J Nutr. 2008;138(6):1250S-1254S.
7. Sleator RD, et al. New frontiers in probiotic research. Lett Appl Microbiol. 2008;46(2):143-147.
8. Di Marzio L, et al. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer. 2001;40(2):185-196.
9. de Moreno de LeBlanc A, et al. The application of probiotics in cancer. Br J Nutr. 2007;98(Suppl 1):S105-S110.
10. Goldin BR. Clinical indications for probiotics: An overview. Clin Infect Dis. 2008;46(Suppl 2):S96-S100.
11. Macpherson AJ, et al. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662-1665.
12. Fisher GJ, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470.
13. Bojar RA, et al. Review: The human cutaneous microflora and factors controlling colonisation. World J Microbiol Biotechnol. 2002;18 (9):889-903.
14. Cogen AL, et al. Skin microbiota: A source of disease or defencé. Br J Dermatol. 2008;158(3):442-455.
15. Ouwehand AC, et al. Probiotics for the skin: A new area of potential application? Lett. Appl Microbiol. 2003;36(5):327-331.
16. Tannock GW. Normal Microflora. An Introduction to Microbes Inhabiting the Human Body. London: Chapman & Hall, 1995.
17. Suomalainen R, et al. Propionic acid bacteria as protective cultures in fermented milks and breads. Lait. 1999;79:165-174.
18. Fluhr JW, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117:44-51.
19. Fluhr JW, et al. Stratum corneum acidification in neonatal skin: Secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004;122:320-329.
20. Lambers H, et al. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28 (5):359-370.
21. Mauro T. SC pH: Measurement, origins, and functions. In: Elias P, Feingold K (eds) Skin Barrier. New York: Taylor & Francis, 2006, pp. 223-229.
22. Fluhr JW, et al. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol. 2004;123:140-151.
23. Hachem JP, et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol. 2003;121:345-353.
24. Hachem JP, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol. 2005;125:510-520.
25. Waller JM, et al. Age and skin structure and function, a quantitative approach (I): Blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol. 2005;11(4):221-235.
26. Choi EH, et al. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol. 2007;127 (12):2847-2856.
27. Yadav H, et al. Production of free fatty acids and conjugated linoleic acid in probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei during fermentation and storage. Intern. Dairy J. 2007;17(8):1006-1010.
28. Holleran WM, et al. Epidermal sphingolipids: Metabolism, function, and roles in skin disorders. FEBS Lett. 2006;580(23):5456-5466.
29. Di Marzio L, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J Invest Dermatol. 1999;113(1): 98-106.
30. Di Marzio L, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12 (5):615-620.
31. Di Marzio L, et al. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol. 2008;21(1):137-143.
32. Denda M, et al. Age-and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res. 1993;285(7):415-417.
33. Motta S, et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol. 1994;130(4):452-456.
34. Jensen JM, et al. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp Dermatol. 2005;14(8):609-618.
35. Kohen R, et al. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology. 2000;148(2-3):149-157.
36. Hensley K, et al. Reactive oxygen species and protein oxidation in aging: A look back, a look ahead. Arch Biochem Biophys. 2002;397 (2):377-383.
37. Tzaphlidou M. The role of collagen and elastin in aged skin: An image processing approach. Micron. 2004;35(3):73-177.
38. Dalle Carbonare M, et al. Skin photosensitizing agents and the role of reactive oxygen species in photoaging. J Photochem Photobiol. 1992;14(1-2):105-124.
39. Helfrich YR, et al. Overview of skin aging and photoaging. Dermatol Nurs. 2008;20(3):177-183.
40. Kodali VP, et al. Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol J. 2008;3(2):245-251.
41. Cerning J. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiol Rev. 1990;7(1-2):113-130.
42. Welman AD, et al. Exopolysaccharides from lactic acid bacteria: Perspectives and challenges. Trends Biotechnol. 2003;21(6):269-274.
43. Kishk YFM, et al. Free-radical scavenging and antioxidative activities of some polysaccharides in emulsions. LWT Food Sci Technol. 2007;40(2):270-277.
44. Bruno-Bárcena JM, et al. Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Appl Environ Microbiol. 2004;70(8):4702-4710.
45. Kang S, et al. Photoaging and topical tretinoin: Therapy, pathogenesis, and prevention. Arch Dermatol. 1997;133(10):1280-1284.
46. Massagué J. TGF-b signal transduction. Annu Rev Biochem. 1998;67:753-791.
47. Chung JH, et al. Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000;115(2):177-182.
48. Fisher GJ, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470.
49. Varani J, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114(3):480-486.
50. Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev. 2002;123(7):801-810.
51. Ulisse S, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment. Am J Gastroenterol. 2001;96(9):2691-2699.
52. Riccia DN, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis. 2007;13(4):376-385.
53. Moorthy G, et al. Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats. Nutrition. 2007;23(5):424-433.
54. Dorshkind K. The ageing immune system: Is it ever too old to become young again? Nat Rev Immunol. 2009;9(1):57-62.
55. Victor VM, et al. N-acetylcysteine improves in vitro the function of macrophages from mice with endotoxininduced oxidative stress. Free Radic Res. 2002;36:33-45.
56. Dewberry C, et al. Skin cancer in elderly patients. Dermatol Clin North Am. 2004;22:93-96.
57. Nova E, et al. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr. 2007;98(Suppl 1):S90-S95.
58. Chiang BL, et al. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): Optimization and definition of cellular immune responses. Eur J Clin Nutr. 2000;54:849-855.
59. Gill HS, et al. Optimizing immunity and gut function in the elderly. J Nutr Health Aging. 2001;5:80-91.
60. Caramia G, et al. Probiotics and the skin. Clin Dermatol. 2008;26 (1):4-11.
61. Isolauri E. Probiotics in human disease. Am J Clin Nutr. 2001;73: S1142-S1146.
62. Cals-Grierson MM, et al. Nitric oxide function in the skin. Nitric Oxide. 2004;10(4):179-193.
63. Ouwehand AC, et al. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol. 2008;53(1):18-25.
64. Guéniche A, et al. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol. 2006;16:511-517.
65. Peguet-Navarro J, et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UVexposuredouble blind, randomized, placebo controlled clinical trial. Eur J Dermatol. 2008;18:504-511.
66. Canche-Pool EB, et al. Probiotics and autoimmunity: An evolutionary perspective. Med Hypotheses. 2008;70:657-660.
67. Hsu CJ, et al. Emerging treatment of atopic dermatitis. Clin Rev Allergy Immunol. 2007;33:199-203.
68. Railan D, et al. Ablative treatment of photoaging. Dermatol Ther. 2005;18:227-241.
69. Gorbach SL. Probiotics in the Third Millennium. Digest Liver Dis. 2002;34(Suppl 2):2-7.
70. Fan YF, et al. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm. 2006;324:158-167.
71. Hooper LV, et al. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA 1999;17(96):9833-9838.
72. Sheehan VM, et al. Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl Environ Microbiology. 2006;72(3):2170-2177.
73. Sheehan VM, et al. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiol. 2007;153(10):3563-3571.
74. Saunders S, et al. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces. 2007;55(2): 138-142.
75. Thurnheer T, et al. Multiplex FISH analysis of a six-species bacterial biofilm. J Microbiol Methods. 2004;56:37-47.